Liraglutide's Efficacy and Safety Investigated for Obesity with Metabolism-Associated Fatty Liver Disease
Efficacy and Safety of Liraglutide in the Treatment of Obesity Combined With Metabolism Associated Fatty Liver Disease
Abstract
A 3-month clinical trial investigated liraglutide's efficacy and safety in patients with obesity and MAFLD, comparing it to orlistat and lifestyle intervention.